Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CACNA1H - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SRRM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928495 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PCDHB13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLXND1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NKX3-1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NEK4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STARD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TLR8-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHF20L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPPB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GOPC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCTN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIF25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PALMD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on